Most people do not want glaucoma surgery.

They want to know whether surgery is actually necessary.

That is the right instinct. Glaucoma care should move in steps: measure the optic nerve risk, set a pressure goal, try the least invasive option that is likely to work, and keep watching the visual field over time.

This article explains when drops, SLT laser, MIGS, sustained-release medication, cataract surgery, or traditional glaucoma surgery may enter the conversation. For procedure details, use the MIGS glaucoma surgery page. If the diagnosis or pressure goal is still unclear, start with the glaucoma specialist in Plano page or the glaucoma overview.

The question is not just your eye pressure number

Eye pressure matters, but it is not the whole story.

A useful glaucoma evaluation looks at:

Your pressure history, not one isolated reading.
OCT optic nerve imaging.
Visual field testing.
Corneal thickness.
Drainage-angle anatomy.
Cataract status.
Current and prior glaucoma drops.
Side effects, allergies, redness, and dry eye from drops.
Family history and rate of change.

Two patients can both have pressure of 21 and need different plans. One may be stable with monitoring. Another may be losing visual field and need a lower target pressure quickly.

That is why a good glaucoma surgeon consultation starts with the pressure goal.

When drops may still be enough

Glaucoma drops are still useful for many patients.

Drops may be enough when:

The optic nerve is stable.
Visual fields are not worsening.
Pressure is at or near the target.
The patient can use drops reliably.
The drops are tolerated without major redness, burning, allergy, or cost problems.

The downside is that glaucoma is long-term. A plan that depends on perfect daily drop use can fail if the drops irritate the eyes, are forgotten, become unaffordable, or are difficult to place correctly.

Where SLT laser fits

Selective laser trabeculoplasty, often called SLT, can help lower pressure by improving the eye's natural drainage function.

SLT may be discussed when:

A patient wants to reduce drop dependence.
Drops are causing irritation.
Adherence is difficult.
The eye has open-angle anatomy.
The pressure goal is realistic for laser treatment.

SLT is not the same as MIGS. It is an in-office, no-incision laser procedure, not an implant or surgical drainage procedure. Some patients do well with SLT for a meaningful period. Others still need drops, MIGS, or another pressure-lowering step later. That is why a drop-reduction discussion should compare SLT, medication changes, sustained-release implants, and MIGS before jumping straight to surgery.

When MIGS should be discussed

MIGS stands for minimally invasive glaucoma surgery; some sources call the same category micro-invasive glaucoma surgery or M.I.G.S. It is a family of procedures designed to lower pressure with less tissue disruption than traditional glaucoma surgery.

MIGS may be worth discussing when:

Drops are not controlling pressure well enough.
Drops cause redness, burning, allergy, or surface disease.
The schedule is hard to follow.
There is mild-to-moderate open-angle glaucoma.
Cataract surgery is already being planned.
The pressure target fits what MIGS can reasonably achieve.
The drainage angle anatomy is appropriate.

At Visionary Eye Surgery, MIGS options include iStent, Hydrus Microstent, goniotomy, canaloplasty, Durysta, and iDose TR.

These do not all work the same way. Some improve drainage through glaucoma stents or angle-based treatment. Some deliver medication inside the eye. Some are commonly paired with cataract surgery. The correct choice depends on anatomy, pressure goal, medication burden, and cataract timing.

Cataract timing can change the plan

Many MIGS procedures are often combined with cataract surgery because the eye is already being treated surgically.

That can make sense when:

Cataracts are affecting vision.
Glaucoma is mild to moderate.
The drainage angle is open.
The pressure goal fits a MIGS-level intervention.
The patient wants to reduce drops after cataract surgery.

Combined cataract and MIGS surgery can reduce the number of procedures and may reduce medication burden. But cataract timing should not be forced just to access MIGS. The cataract and glaucoma plan should both make sense.

Where Durysta and iDose fit

Durysta and iDose TR are medication-delivery options placed inside the eye.

They may fit patients whose main issue is daily drop burden, drop intolerance, or adherence. They still require careful testing.

Durysta is a biodegradable bimatoprost implant designed to release medication for about 3 to 4 months and is currently limited to a single implant per eye without retreatment. iDose TR is a travoprost intracameral implant approved for open-angle glaucoma or ocular hypertension, with official patient information describing pressure control shown up to 3 years. Corneal endothelial testing and routine monitoring are built into candidacy and readministration decisions.

That means these are not casual convenience procedures. They are medical options for pressure control when the eye fits the safety profile.

When traditional glaucoma surgery is still needed

MIGS is not the answer for every glaucoma patient.

Traditional glaucoma surgery may be needed when:

Glaucoma is advanced.
The target pressure must be very low.
Visual fields are worsening despite treatment.
Prior MIGS, laser, or drops have not worked.
The anatomy does not fit MIGS.
The surgeon believes a stronger pressure-lowering procedure is safer for the optic nerve.

That can include procedures such as trabeculectomy, tube shunt surgery, or other glaucoma operations. These are more intensive than MIGS, but they still matter for patients whose glaucoma needs stronger pressure control.

When to get a glaucoma second opinion

A second opinion is reasonable if:

You were told you need surgery but do not understand why.
You keep adding drops and still have pressure concerns.
Drops are damaging your ocular surface.
Your visual fields or OCT scans are worsening.
You have cataracts and glaucoma and want to know whether a combined plan makes sense.
You want to compare drops, SLT, MIGS, Durysta, iDose, and traditional surgery before deciding.

Bring your pressure records, medication list, OCT scans, visual fields, cataract notes, and prior surgical history if you have them.

When comparing glaucoma surgeons, look for a clear pressure goal and a clear boundary between monitoring, drops, SLT, MIGS, cataract-combined treatment, and referral for traditional glaucoma surgery. The right recommendation should explain why the optic nerve needs that step now.

A second opinion should also say when not to operate. Some patients need better monitoring, a cleaner drop plan, or SLT before any incision is reasonable. Others need a traditional glaucoma surgery referral because MIGS is unlikely to reach a low enough pressure target. The value is in matching the pressure goal to the least risky option that can protect the optic nerve.

How to compare glaucoma surgery options in Texas

Many glaucoma surgery conversations in Texas list the same procedures: drops, selective laser trabeculoplasty, SLT, iStent, Hydrus, canaloplasty, goniotomy, Durysta, iDose, trabeculectomy, and tube shunts. The gap is usually not the device list; it is whether the plan explains which pressure problem each option is meant to solve.

The consultation that helps most is the one that explains the decision order:

First, confirm the diagnosis and pressure trend.
Then compare OCT, visual field, corneal thickness, and drainage-angle findings.
Then decide whether the problem is pressure level, drop adherence, drop irritation, cataract timing, or advanced disease.
Then choose monitoring, drops, SLT, sustained-release medication, MIGS, cataract-combined treatment, or traditional glaucoma surgery referral.

A confident recommendation should explain why the optic nerve needs intervention now and what would make a less invasive option insufficient.

Sources and clinical references

These sources support general clinical context. A target pressure and treatment plan require examination and review of pressure, OCT, and visual-field history.

Related resources

Bottom line

You may need glaucoma surgery if pressure is not at target, the optic nerve is changing, visual fields are worsening, drops are not tolerated, or cataract timing creates an opportunity for a combined MIGS plan.

You may not need surgery yet if pressure is controlled, the optic nerve is stable, and drops or laser are working.

The safest answer comes from a pressure-goal evaluation, not from choosing a device name online.

Start with our MIGS glaucoma surgery page, compare MIGS vs glaucoma drops, review the glaucoma specialist in Plano page, or schedule a glaucoma second opinion if your pressure, drops, or cataract timing are unclear.

Medically Reviewed by Dr. Shehz, DO

Board-Certified Ophthalmologist

Dr. Shehzad Batliwala, DO—better known as Dr. Shehz—is a board-certified ophthalmologist and eye surgeon who brings both technical precision and genuine compassion to every patient he treats.

Explore this content with AI

Open this article in your preferred AI assistant for a plain-English summary, action steps, and questions to ask before booking a consultation.